Latest rEVO Biologics Stories
2013-01-03 20:20:35
FRAMINGHAM, Mass., Jan. 3, 2013 /PRNewswire/ -- GTC Biotherapeutics announced today that it has changed its name to rEVO Biologics. The name change reflects the recent commercial growth of the company, and better aligns with the company's business strategy of evolving recombinant medicine for the treatment of rare diseases. (Logo: http://photos.prnewswire.com/prnh/20130103/NE36742LOGO ) "Our company is taking a revolutionary approach to the development of recombinant therapies, as...
